INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/26/2023
Back to search
Official data from USPTO
CERTAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
11/26/2023
Trademark type
Word
Nice classes
1, 5, 9
Filing date
08/03/2011
Registration date
09/04/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2023
Last transaction
02/18/2023
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Hilden, DE
Examiner
STRUCK, ROBERT J
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
QIAGEN GmbH
QIAGEN GmbH
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological products used in industry and sciencenucleic acidsenzymespolymerasesreagents for staining and markingmolecular probesbufferaqueous and non-aqueous solutions of alcohols and saltsdistilled and purified watersilica in powderedgranulate and gel form and magnetic particles in fluid formreagents and solvents for sample preparationthe modification and manipulation of cellsfor conducting markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesfor identifying contamination through biomolecules; namelyreagents for research purposes; kits containing chemicals for sample preparationthe modification and manipulation of cellsfor the markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis of biopolymersfor identifying contamination through biomoleculesin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids from biological or biochemical sample material for laboratory or research use
Class 5
Diagnostic preparations for medical purposes; diagnostic preparations for medical and veterinary usein particular for sample preparationthe modification and manipulation of cellsfor conducting the markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substanceschemicalbiochemical and biotechnological preparationsin particular diagnostic reagents and solvents for medical and veterinary use for sample preparationthe modification and manipulation of cellsfor conducting markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis methods for biopolymersfor identifying contamination through biomoleculesin particular nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes; kits containing medical and veterinary diagnostic preparationsin particular for sample preparationthe modification and manipulation of cellsfor the markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis of biopolymersfor identifying contamination through biomoleculesin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids from biological or biochemical sample material
Class 9
Scientific apparatusinstruments and equipmentin particular for research and experimentation purposeslaboratory apparatusmeasuring apparatus and instruments in the nature of chromatography columnsrobots and preprogrammed smart cards for proteinDNA and RNA purification protocolsfor the use of medical and veterinary diagnostic preparationsin particular for sample preparationthe modification and manipulation of cellsfor the markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis of biopolymersfor identifying contamination through biomoleculesin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids from biological or biochemical sample materialall the aforesaid goods included in this class
Publications
History of USPTO decisions and trademark events.
52 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/25/2023
INPC
INVALIDATION PROCESSED
10/25/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/18/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/19/2023
71AG
REGISTERED-SEC.71 ACCEPTED
02/18/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/13/2023
ES71
TEAS SECTION 71 RECEIVED
08/08/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/04/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/19/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/18/2019
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/26/2019
INPC
INVALIDATION PROCESSED
07/26/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/11/2019
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
10/11/2018
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
10/11/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/17/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
08/31/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/04/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/23/2012
GPNX
NOTIFICATION PROCESSED BY IB
12/10/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/05/2012
FIMP
FINAL DISPOSITION PROCESSED
12/05/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/04/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/19/2012
PUBO
PUBLISHED FOR OPPOSITION
06/19/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/30/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/30/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/30/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/16/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
05/15/2012
ALIE
ASSIGNED TO LIE
05/15/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/14/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
05/14/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/14/2012
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/12/2012
GNFR
FINAL REFUSAL E-MAILED
04/12/2012
CNFR
FINAL REFUSAL WRITTEN
04/12/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2012
RFNT
REFUSAL PROCESSED BY IB
12/24/2011
MAFR
APPLICATION FILING RECEIPT MAILED
12/09/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/07/2011
RFRR
REFUSAL PROCESSED BY MPU
12/07/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/07/2011
CNRT
NON-FINAL ACTION WRITTEN
12/06/2011
DOCK
ASSIGNED TO EXAMINER
12/05/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/01/2011
Continuous trademark protection
Get notified about every new filing that threatens CERTAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.